This product page is intended for qualified business, laboratory, or research-related inquiry. Availability and permitted use depend on destination country and local regulations.
Confirm product name, preferred specification, quantity, and packaging requirement before quotation.
Ask for available specification sheet, packaging details, or product-related quality documentation.
Use Inquiry Cart or the quote form so our team can reply with availability, lead time, and shipping communication.
Composition: It is a fixed-dose combination of the long-acting amylin analog Cagrilintide and the glucagon-like peptide-1 receptor agonist Semaglutide.
Mechanism of action: Cagrilintide, as an amylin receptor agonist, can significantly suppress appetite and effectively delay gastric emptying; Semaglutide, as a GLP-1 receptor agonist, can significantly enhance insulin secretion and strongly inhibit the release of glucagon.
At the same time, it further slows gastric emptying. The combination of the two is excellent in blood sugar control and weight management.
Request a Quote
Send your quantity, destination country, and preferred contact method. Our team will reply with availability and quotation details.